Covid-19 Impact on Global Upper Extremities Disorders Treatment Market Size, Status and Forecast 2020-2026

July 2020 | 93 pages | ID: CC0A49B3F97CEN
QYResearch

Abstracts

Upper Extremities Disorders Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Upper Extremities Disorders Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Upper Extremities Disorders Treatment market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Upper Extremities Disorders Treatment industry.
The key players covered in this study

• Integra LifeSciences
• DePuy Synthes
• Stryker
• Zimmer Biomet
• Smith and Nephew
• Wright Medical Group N.V.
• Exactech
• Arthrex
• CONMED Corporation
• Acumed
• Bioretec
• Advanced Orthopaedic Solutions

Market segment by Type, the product can be split into

• Replacement and Fracture
• Nerve Diseases
• Soft Issue Injuries

Market segment by Application, split into

• Hospitals and Surgical Centers
• Orthopedic Surgical Centers
• Ambulatory Surgical Centers

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Upper Extremities Disorders Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Upper Extremities Disorders Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Upper Extremities Disorders Treatment are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Upper Extremities Disorders Treatment Revenue
1.4 Covid-19 Implications on Market by Type
  1.4.1 Global Upper Extremities Disorders Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Replacement and Fracture
  1.4.3 Nerve Diseases
  1.4.4 Soft Issue Injuries
1.5 Market by Application
  1.5.1 Global Upper Extremities Disorders Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals and Surgical Centers
  1.5.3 Orthopedic Surgical Centers
  1.5.4 Ambulatory Surgical Centers
1.6 Coronavirus Disease 2019 (Covid-19): Upper Extremities Disorders Treatment Industry Impact
  1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
  1.6.2 Covid-19 Impact: Commodity Prices Indices
  1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Covid-19 Implications on Global Upper Extremities Disorders Treatment Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Upper Extremities Disorders Treatment Growth Trends by Regions
  2.2.1 Upper Extremities Disorders Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Upper Extremities Disorders Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Upper Extremities Disorders Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Upper Extremities Disorders Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Upper Extremities Disorders Treatment Players (Opinion Leaders)

3 COVID-19 IMPLICATIONS ON COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Upper Extremities Disorders Treatment Players by Market Size
  3.1.1 Global Top Upper Extremities Disorders Treatment Players by Revenue (2015-2020)
  3.1.2 Global Upper Extremities Disorders Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Upper Extremities Disorders Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Upper Extremities Disorders Treatment Market Concentration Ratio
  3.2.1 Global Upper Extremities Disorders Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Upper Extremities Disorders Treatment Revenue in 2019
3.3 Upper Extremities Disorders Treatment Key Players Head office and Area Served
3.4 Key Players Upper Extremities Disorders Treatment Product Solution and Service
3.5 Date of Enter into Upper Extremities Disorders Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 COVID-19 IMPLICATIONS ON MARKET SIZE BY TYPE (2015-2026)

4.1 Global Upper Extremities Disorders Treatment Historic Market Size by Type (2015-2020)
4.2 Global Upper Extremities Disorders Treatment Forecasted Market Size by Type (2021-2026)

5 COVID-19 IMPLICATIONS ON MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Upper Extremities Disorders Treatment Market Size by Application (2015-2020)
5.2 Global Upper Extremities Disorders Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA IMPACT OF COVID-19

6.1 North America Upper Extremities Disorders Treatment Market Size (2015-2020)
6.2 Upper Extremities Disorders Treatment Key Players in North America (2019-2020)
6.3 North America Upper Extremities Disorders Treatment Market Size by Type (2015-2020)
6.4 North America Upper Extremities Disorders Treatment Market Size by Application (2015-2020)

7 EUROPE IMPACT OF COVID-19

7.1 Europe Upper Extremities Disorders Treatment Market Size (2015-2020)
7.2 Upper Extremities Disorders Treatment Key Players in Europe (2019-2020)
7.3 Europe Upper Extremities Disorders Treatment Market Size by Type (2015-2020)
7.4 Europe Upper Extremities Disorders Treatment Market Size by Application (2015-2020)

8 CHINA IMPACT OF COVID-19

8.1 China Upper Extremities Disorders Treatment Market Size (2015-2020)
8.2 Upper Extremities Disorders Treatment Key Players in China (2019-2020)
8.3 China Upper Extremities Disorders Treatment Market Size by Type (2015-2020)
8.4 China Upper Extremities Disorders Treatment Market Size by Application (2015-2020)

9 JAPAN IMPACT OF COVID-19

9.1 Japan Upper Extremities Disorders Treatment Market Size (2015-2020)
9.2 Upper Extremities Disorders Treatment Key Players in Japan (2019-2020)
9.3 Japan Upper Extremities Disorders Treatment Market Size by Type (2015-2020)
9.4 Japan Upper Extremities Disorders Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA IMPACT OF COVID-19

10.1 Southeast Asia Upper Extremities Disorders Treatment Market Size (2015-2020)
10.2 Upper Extremities Disorders Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Upper Extremities Disorders Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Upper Extremities Disorders Treatment Market Size by Application (2015-2020)

11 INDIA IMPACT OF COVID-19

11.1 India Upper Extremities Disorders Treatment Market Size (2015-2020)
11.2 Upper Extremities Disorders Treatment Key Players in India (2019-2020)
11.3 India Upper Extremities Disorders Treatment Market Size by Type (2015-2020)
11.4 India Upper Extremities Disorders Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA IMPACT OF COVID-19

12.1 Central & South America Upper Extremities Disorders Treatment Market Size (2015-2020)
12.2 Upper Extremities Disorders Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Upper Extremities Disorders Treatment Market Size by Type (2015-2020)
12.4 Central & South America Upper Extremities Disorders Treatment Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 Integra LifeSciences
  13.1.1 Integra LifeSciences Company Details
  13.1.2 Integra LifeSciences Business Overview and Its Total Revenue
  13.1.3 Integra LifeSciences Upper Extremities Disorders Treatment Introduction
  13.1.4 Integra LifeSciences Revenue in Upper Extremities Disorders Treatment Business (2015-2020))
  13.1.5 Integra LifeSciences Recent Development and Reaction to COVID-19
13.2 DePuy Synthes
  13.2.1 DePuy Synthes Company Details
  13.2.2 DePuy Synthes Business Overview and Its Total Revenue
  13.2.3 DePuy Synthes Upper Extremities Disorders Treatment Introduction
  13.2.4 DePuy Synthes Revenue in Upper Extremities Disorders Treatment Business (2015-2020)
  13.2.5 DePuy Synthes Recent Development and Reaction to COVID-19
13.3 Stryker
  13.3.1 Stryker Company Details
  13.3.2 Stryker Business Overview and Its Total Revenue
  13.3.3 Stryker Upper Extremities Disorders Treatment Introduction
  13.3.4 Stryker Revenue in Upper Extremities Disorders Treatment Business (2015-2020)
  13.3.5 Stryker Recent Development and Reaction to COVID-19
13.4 Zimmer Biomet
  13.4.1 Zimmer Biomet Company Details
  13.4.2 Zimmer Biomet Business Overview and Its Total Revenue
  13.4.3 Zimmer Biomet Upper Extremities Disorders Treatment Introduction
  13.4.4 Zimmer Biomet Revenue in Upper Extremities Disorders Treatment Business (2015-2020)
  13.4.5 Zimmer Biomet Recent Development and Reaction to COVID-19
13.5 Smith and Nephew
  13.5.1 Smith and Nephew Company Details
  13.5.2 Smith and Nephew Business Overview and Its Total Revenue
  13.5.3 Smith and Nephew Upper Extremities Disorders Treatment Introduction
  13.5.4 Smith and Nephew Revenue in Upper Extremities Disorders Treatment Business (2015-2020)
  13.5.5 Smith and Nephew Recent Development and Reaction to COVID-19
13.6 Wright Medical Group N.V.
  13.6.1 Wright Medical Group N.V. Company Details
  13.6.2 Wright Medical Group N.V. Business Overview and Its Total Revenue
  13.6.3 Wright Medical Group N.V. Upper Extremities Disorders Treatment Introduction
  13.6.4 Wright Medical Group N.V. Revenue in Upper Extremities Disorders Treatment Business (2015-2020)
  13.6.5 Wright Medical Group N.V. Recent Development and Reaction to COVID-19
13.7 Exactech
  13.7.1 Exactech Company Details
  13.7.2 Exactech Business Overview and Its Total Revenue
  13.7.3 Exactech Upper Extremities Disorders Treatment Introduction
  13.7.4 Exactech Revenue in Upper Extremities Disorders Treatment Business (2015-2020)
  13.7.5 Exactech Recent Development and Reaction to COVID-19
13.8 Arthrex
  13.8.1 Arthrex Company Details
  13.8.2 Arthrex Business Overview and Its Total Revenue
  13.8.3 Arthrex Upper Extremities Disorders Treatment Introduction
  13.8.4 Arthrex Revenue in Upper Extremities Disorders Treatment Business (2015-2020)
  13.8.5 Arthrex Recent Development and Reaction to COVID-19
13.9 CONMED Corporation
  13.9.1 CONMED Corporation Company Details
  13.9.2 CONMED Corporation Business Overview and Its Total Revenue
  13.9.3 CONMED Corporation Upper Extremities Disorders Treatment Introduction
  13.9.4 CONMED Corporation Revenue in Upper Extremities Disorders Treatment Business (2015-2020)
  13.9.5 CONMED Corporation Recent Development and Reaction to COVID-19
13.10 Acumed
  13.10.1 Acumed Company Details
  13.10.2 Acumed Business Overview and Its Total Revenue
  13.10.3 Acumed Upper Extremities Disorders Treatment Introduction
  13.10.4 Acumed Revenue in Upper Extremities Disorders Treatment Business (2015-2020)
  13.10.5 Acumed Recent Development and Reaction to COVID-19
13.11 Bioretec
  10.11.1 Bioretec Company Details
  10.11.2 Bioretec Business Overview and Its Total Revenue
  10.11.3 Bioretec Upper Extremities Disorders Treatment Introduction
  10.11.4 Bioretec Revenue in Upper Extremities Disorders Treatment Business (2015-2020)
  10.11.5 Bioretec Recent Development and Reaction to COVID-19
13.12 Advanced Orthopaedic Solutions
  10.12.1 Advanced Orthopaedic Solutions Company Details
  10.12.2 Advanced Orthopaedic Solutions Business Overview and Its Total Revenue
  10.12.3 Advanced Orthopaedic Solutions Upper Extremities Disorders Treatment Introduction
  10.12.4 Advanced Orthopaedic Solutions Revenue in Upper Extremities Disorders Treatment Business (2015-2020)
  10.12.5 Advanced Orthopaedic Solutions Recent Development and Reaction to COVID-19

14ANALYST'S VIEWPOINTS/CONCLUSIONS

15APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Upper Extremities Disorders Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Upper Extremities Disorders Treatment Revenue
Table 3. Ranking of Global Top Upper Extremities Disorders Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Upper Extremities Disorders Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Replacement and Fracture
Table 6. Key Players of Nerve Diseases
Table 7. Key Players of Soft Issue Injuries
Table 8. COVID-19 Impact Global Market: (Four Upper Extremities Disorders Treatment Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Upper Extremities Disorders Treatment Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Upper Extremities Disorders Treatment Players to Combat Covid-19 Impact
Table 13. Global Upper Extremities Disorders Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Upper Extremities Disorders Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Upper Extremities Disorders Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Upper Extremities Disorders Treatment Market Share by Regions (2015-2020)
Table 17. Global Upper Extremities Disorders Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Upper Extremities Disorders Treatment Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Upper Extremities Disorders Treatment Market Growth Strategy
Table 23. Main Points Interviewed from Key Upper Extremities Disorders Treatment Players
Table 24. Global Upper Extremities Disorders Treatment Revenue by Players (2015-2020) (Million US$)
Table 25. Global Upper Extremities Disorders Treatment Market Share by Players (2015-2020)
Table 26. Global Top Upper Extremities Disorders Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Upper Extremities Disorders Treatment as of 2019)
Table 27. Global Upper Extremities Disorders Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Upper Extremities Disorders Treatment Product Solution and Service
Table 30. Date of Enter into Upper Extremities Disorders Treatment Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Upper Extremities Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 33. Global Upper Extremities Disorders Treatment Market Size Share by Type (2015-2020)
Table 34. Global Upper Extremities Disorders Treatment Revenue Market Share by Type (2021-2026)
Table 35. Global Upper Extremities Disorders Treatment Market Size Share by Application (2015-2020)
Table 36. Global Upper Extremities Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. Global Upper Extremities Disorders Treatment Market Size Share by Application (2021-2026)
Table 38. North America Key Players Upper Extremities Disorders Treatment Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Upper Extremities Disorders Treatment Market Share (2019-2020)
Table 40. North America Upper Extremities Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. North America Upper Extremities Disorders Treatment Market Share by Type (2015-2020)
Table 42. North America Upper Extremities Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. North America Upper Extremities Disorders Treatment Market Share by Application (2015-2020)
Table 44. Europe Key Players Upper Extremities Disorders Treatment Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Upper Extremities Disorders Treatment Market Share (2019-2020)
Table 46. Europe Upper Extremities Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Upper Extremities Disorders Treatment Market Share by Type (2015-2020)
Table 48. Europe Upper Extremities Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Upper Extremities Disorders Treatment Market Share by Application (2015-2020)
Table 50. China Key Players Upper Extremities Disorders Treatment Revenue (2019-2020) (Million US$)
Table 51. China Key Players Upper Extremities Disorders Treatment Market Share (2019-2020)
Table 52. China Upper Extremities Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. China Upper Extremities Disorders Treatment Market Share by Type (2015-2020)
Table 54. China Upper Extremities Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. China Upper Extremities Disorders Treatment Market Share by Application (2015-2020)
Table 56. Japan Key Players Upper Extremities Disorders Treatment Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Upper Extremities Disorders Treatment Market Share (2019-2020)
Table 58. Japan Upper Extremities Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Upper Extremities Disorders Treatment Market Share by Type (2015-2020)
Table 60. Japan Upper Extremities Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Upper Extremities Disorders Treatment Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Upper Extremities Disorders Treatment Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Upper Extremities Disorders Treatment Market Share (2019-2020)
Table 64. Southeast Asia Upper Extremities Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Upper Extremities Disorders Treatment Market Share by Type (2015-2020)
Table 66. Southeast Asia Upper Extremities Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Upper Extremities Disorders Treatment Market Share by Application (2015-2020)
Table 68. India Key Players Upper Extremities Disorders Treatment Revenue (2019-2020) (Million US$)
Table 69. India Key Players Upper Extremities Disorders Treatment Market Share (2019-2020)
Table 70. India Upper Extremities Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. India Upper Extremities Disorders Treatment Market Share by Type (2015-2020)
Table 72. India Upper Extremities Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. India Upper Extremities Disorders Treatment Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Upper Extremities Disorders Treatment Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Upper Extremities Disorders Treatment Market Share (2019-2020)
Table 76. Central & South America Upper Extremities Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Upper Extremities Disorders Treatment Market Share by Type (2015-2020)
Table 78. Central & South America Upper Extremities Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Upper Extremities Disorders Treatment Market Share by Application (2015-2020)
Table 80. Integra LifeSciences Company Details
Table 81. Integra LifeSciences Business Overview
Table 82. Integra LifeSciences Product
Table 83. Integra LifeSciences Revenue in Upper Extremities Disorders Treatment Business (2015-2020) (Million US$)
Table 84. Integra LifeSciences Recent Development
Table 85. DePuy Synthes Company Details
Table 86. DePuy Synthes Business Overview
Table 87. DePuy Synthes Product
Table 88. DePuy Synthes Revenue in Upper Extremities Disorders Treatment Business (2015-2020) (Million US$)
Table 89. DePuy Synthes Recent Development
Table 90. Stryker Company Details
Table 91. Stryker Business Overview
Table 92. Stryker Product
Table 93. Stryker Revenue in Upper Extremities Disorders Treatment Business (2015-2020) (Million US$)
Table 94. Stryker Recent Development
Table 95. Zimmer Biomet Company Details
Table 96. Zimmer Biomet Business Overview
Table 97. Zimmer Biomet Product
Table 98. Zimmer Biomet Revenue in Upper Extremities Disorders Treatment Business (2015-2020) (Million US$)
Table 99. Zimmer Biomet Recent Development
Table 100. Smith and Nephew Company Details
Table 101. Smith and Nephew Business Overview
Table 102. Smith and Nephew Product
Table 103. Smith and Nephew Revenue in Upper Extremities Disorders Treatment Business (2015-2020) (Million US$)
Table 104. Smith and Nephew Recent Development
Table 105. Wright Medical Group N.V. Company Details
Table 106. Wright Medical Group N.V. Business Overview
Table 107. Wright Medical Group N.V. Product
Table 108. Wright Medical Group N.V. Revenue in Upper Extremities Disorders Treatment Business (2015-2020) (Million US$)
Table 109. Wright Medical Group N.V. Recent Development
Table 110. Exactech Company Details
Table 111. Exactech Business Overview
Table 112. Exactech Product
Table 113. Exactech Revenue in Upper Extremities Disorders Treatment Business (2015-2020) (Million US$)
Table 114. Exactech Recent Development
Table 115. Arthrex Business Overview
Table 116. Arthrex Product
Table 117. Arthrex Company Details
Table 118. Arthrex Revenue in Upper Extremities Disorders Treatment Business (2015-2020) (Million US$)
Table 119. Arthrex Recent Development
Table 120. CONMED Corporation Company Details
Table 121. CONMED Corporation Business Overview
Table 122. CONMED Corporation Product
Table 123. CONMED Corporation Revenue in Upper Extremities Disorders Treatment Business (2015-2020) (Million US$)
Table 124. CONMED Corporation Recent Development
Table 125. Acumed Company Details
Table 126. Acumed Business Overview
Table 127. Acumed Product
Table 128. Acumed Revenue in Upper Extremities Disorders Treatment Business (2015-2020) (Million US$)
Table 129. Acumed Recent Development
Table 130. Bioretec Company Details
Table 131. Bioretec Business Overview
Table 132. Bioretec Product
Table 133. Bioretec Revenue in Upper Extremities Disorders Treatment Business (2015-2020) (Million US$)
Table 134. Bioretec Recent Development
Table 135. Advanced Orthopaedic Solutions Company Details
Table 136. Advanced Orthopaedic Solutions Business Overview
Table 137. Advanced Orthopaedic Solutions Product
Table 138. Advanced Orthopaedic Solutions Revenue in Upper Extremities Disorders Treatment Business (2015-2020) (Million US$)
Table 139. Advanced Orthopaedic Solutions Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Upper Extremities Disorders Treatment Market Share by Type: 2020 VS 2026
Figure 2. Replacement and Fracture Features
Figure 3. Nerve Diseases Features
Figure 4. Soft Issue Injuries Features
Figure 5. Global Upper Extremities Disorders Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals and Surgical Centers Case Studies
Figure 7. Orthopedic Surgical Centers Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Upper Extremities Disorders Treatment Report Years Considered
Figure 10. Global Upper Extremities Disorders Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Upper Extremities Disorders Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Upper Extremities Disorders Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Upper Extremities Disorders Treatment Market Share by Players in 2019
Figure 15. Global Top Upper Extremities Disorders Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Upper Extremities Disorders Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Upper Extremities Disorders Treatment Revenue in 2019
Figure 17. North America Upper Extremities Disorders Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Upper Extremities Disorders Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Upper Extremities Disorders Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Upper Extremities Disorders Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Upper Extremities Disorders Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Upper Extremities Disorders Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Upper Extremities Disorders Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Integra LifeSciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Integra LifeSciences Revenue Growth Rate in Upper Extremities Disorders Treatment Business (2015-2020)
Figure 26. DePuy Synthes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. DePuy Synthes Revenue Growth Rate in Upper Extremities Disorders Treatment Business (2015-2020)
Figure 28. Stryker Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Stryker Revenue Growth Rate in Upper Extremities Disorders Treatment Business (2015-2020)
Figure 30. Zimmer Biomet Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Zimmer Biomet Revenue Growth Rate in Upper Extremities Disorders Treatment Business (2015-2020)
Figure 32. Smith and Nephew Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Smith and Nephew Revenue Growth Rate in Upper Extremities Disorders Treatment Business (2015-2020)
Figure 34. Wright Medical Group N.V. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Wright Medical Group N.V. Revenue Growth Rate in Upper Extremities Disorders Treatment Business (2015-2020)
Figure 36. Exactech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Exactech Revenue Growth Rate in Upper Extremities Disorders Treatment Business (2015-2020)
Figure 38. Arthrex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Arthrex Revenue Growth Rate in Upper Extremities Disorders Treatment Business (2015-2020)
Figure 40. CONMED Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. CONMED Corporation Revenue Growth Rate in Upper Extremities Disorders Treatment Business (2015-2020)
Figure 42. Acumed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Acumed Revenue Growth Rate in Upper Extremities Disorders Treatment Business (2015-2020)
Figure 44. Bioretec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Bioretec Revenue Growth Rate in Upper Extremities Disorders Treatment Business (2015-2020)
Figure 46. Advanced Orthopaedic Solutions Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Advanced Orthopaedic Solutions Revenue Growth Rate in Upper Extremities Disorders Treatment Business (2015-2020)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed